StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.03−0.51 (-20.08%)

Close on Nov 19, 2026Market cap $16.93MP/E –Yield –

Evaxion A/S gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Evaxion A/S

Evaxion A/S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Evaxion A/S figures

See a number that looks wrong?